Selumetinib in Patients Receiving Pemetrexed and Platinum-based Chemotherapy in Advanced or Metastatic KRAS Wildtype or Unknown Non-Squamous NSCLC
Conditions
- Non-Small Cell Lung Cancer
Interventions
- DRUG: Selumetinib
- DRUG: Pemetrexed
- DRUG: Cisplatin
- DRUG: Carboplatin
Sponsor
Canadian Cancer Trials Group
Collaborators